0800 0351 999

0239 2483 322

Compass House,
57 Meridian Centre,
North Street,

Expert Services
Expert Services
A quality personalised service from a law firm based in Portsmouth/Havant, Southampton and Liverpool. We can help you. We will provide free first advice. Our lawyers are specialists in their areas of work.
Our Team
Our Team
We have specialist lawyers, many of whom are recognised as leaders in their respective fields and also share our unique focus on quality service and putting our clients first. Click here to find out more about our legal experts.
Fees & Figures
Fees & Figures
We provide a number of payment options: No Win No Fee, Legal Aid, Monthly payments, Fixed fee payment and other options. Here you can learn more about our payment options.

Cancer Treatment – Two cancer drugs given a go ahead

Women suffering from metastatic breast cancer can access new drugs for cancer treatment.

The National Institute for Health and Care Excellent (NICE) has now confirmed that women suffering with metastatic breast cancer across England will have access to two new drugs, Palbociclib and Ribociclib.

Approximately 8,000 individuals in England will benefit and receive Palbociclib or Ribociclib each year.

It has been reported that the drugs have slowed down cancer for approximately 10 months. This delays the start of chemotherapy treatment.

Chemotherapy can have many side effects. Most commonly:

  • fatigue
  • hair loss
  • easy bruising and bleeding
  • anaemia
  • nausea and vomiting etc.

Delays in needing chemotherapy gives women and their family’s time to come to terms with their diagnosis.

In order to receive Palbociclib and Ribociclib, women will have to meet the eligibility criteria.

The criteria is different for each of the drugs.

Women with oestrogen receptor positive breast cancer (diagnosed after cancer had begun to spread) will be entitled to Palbociclib.

Women who has met the above criteria and have also undergone the menopause will be eligible for Ribociclib.

The two drugs can only be taken once a day together with an aromatase inhibitor which block the production of the hormone oestrogen.

Chief Executive at the charity Breast Cancer Now, Baroness Delyth Morgan has said:

“This is a life-changing and long-awaited step forward in treatment for many patients with metastatic breast cancer, potentially offering thousands of women the closest thing they would have to cure in their lifetime.” “Palbociclib and Ribociclib represent an exciting new generation of medicines capable of slowing the spread of incurable breast cancer, and their introduction to NHS care in England is fantastic news for patients and their doctors.” “Around 8,000 women each year can now be given significant extra time before their condition progresses – time that will be truly invaluable to them and their loved ones.”

The Medical Negligence team at Swain & Co Solicitors take a pride in helping individuals. We help many cancer sufferers who, for example, have suffered as a result of the medical practitioners failing to diagnose their cancer in a timely fashion. Often they have suffered more intrusive treatment as a result of this delay in diagnosis of cancer.

The Medical Negligence team at Swain & Co Solicitors regularly win compensation for their clients who have experienced substandard treatment or a failure to provide treatment. If you, a family member or a friend have experienced problems regarding substandard medical treatment contact our team today on 0292 483 322.

No Comments Yet.

Leave a comment

Time limit is exhausted. Please reload CAPTCHA.